Clinical trials provide significant value to Australia’s healthcare system nationally, at an institutional level and at the level of private practice. This value is not just financial but can also be observed in key areas such as equity of access to treatment, improved quality of life (for both participants and patients), collaboration and partnerships, improving workforce education, and defining best practice healthcare. Despite these advantages, the wider and truer value of clinical trials remains underrealised and communication of these values needs to be better appreciated.
As part of their Business Capabilities project within the Clinical Trials Innovation program, the VCCC Alliance undertook a proposal to ascertain how the value of clinical trials could be better understood within a Health Service Organisation (HSO). Working with the knowledge that HSO strategic plans are designed to encapsulate their desired quality of healthcare provision, these were chosen as a focus for analysis. Thematic areas were identified from 12 strategic plans across Victoria and grouped together, along with explanations and references, that demonstrate alignment to clinical trials. The resulting ‘one pager’ document is freely available and offered to assist to communicate, support and justify business cases.
The poster here will reflect the scoping process outlined above and the key findings.